Lower riskDrug recall · FDA · Published June 13, 2019
B. Braun Medical Heparin Sodium Recall: Subpotent Drug Risk
B. Braun Medical recalls heparin sodium 25,000 USP units per 250mL in 5% dextrose injection due to subpotent drug levels. This may cause ineffective blood thinning during medical procedures.
Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.
Take action
Contact the company
📍Recalling firmB. Braun Medical Inc2525 Mcgaw Ave · Irvine, CA 92614-5841
“B. Braun Medical Heparin Sodium Recall: Subpotent Drug Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38640-b-braun-medical-heparin-sodium-recall-subpotent-drug-risk. Based on FDA recall #D-1343-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1343-2019%22&limit=1).
The FDA announced on June 13, 2019, that B. Braun Medical Inc. voluntarily recalled Heparin Sodium 25,000 USP units per 250 mL in 5% Dextrose Injection due to subpotent drug risks. The agency stated the recall was initiated by the firm.
How to tell if you have it
Brand: B. Braun Medical
Product: Heparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCEL Container bag
NDC: 0264-9587-20
Lot #: J7B259
Expiration: 31 Aug 2019
Quantity: 40,176 bags
The hazard
The recall addresses low out-of-specification results for the drug anti-factor IIa potency. This defect means the heparin potency may not meet USP specifications.
Context
GovInfoNow's records show B Braun Medical Inc has 66 other recalls on record since October 15, 2013. Other recent recalls of similar products include Somerset Therapeutics Cisatracurium Besylate Injection Recall (November 26, 2025), OneSource Specialty Pharma Methohexital Sodium Recall (June 7, 2026), and Par Health Buprenorphine Injection Recall (June 12, 2026).
How to tell if you have this one
Check for the product name 'Heparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCEL Container bag'. The lot number J7B259 with expiration date August 31, 2019 is affected.
Brand
B. Braun Medical
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the lot number and expiration date on the product label to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.1 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1343-2019 (June 13, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1343-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.